drugset / Trial / NCT00466856
Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors
Phase 2
Terminated
10 enrolled
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI) · collab
NaSingle-groupOpen-labelTreatment
Summary
RATIONALE: Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. PURPOSE: This phase II trial is studying how well internal radiation therapy works in treating patients with liver metastases from neuroendocrine tumors.
Timeline
- Start
- 2003-12
- Primary completion
- 2006-10
- Completion
- 2007-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Octreotide | Peptide | — | Intravenous |